1
Edgren David Emil, Magruder Judy A, Bhatti Gurdish Kaur: Laminated drug delivery systems. Alza, October 19, 1988: GB2203338-A (15 worldwide citation)

A bilaminated drug dosage form comprises at least 30 weight percent cellulose ether in first and a second laminae with each lamina comprising a different cellulose ether formulation, and a drug in at least one of the laminae.


2
Edgren David Emil, Theeuwes Felix: Aqueous based pharmaceutical coating composition for dosage forms.. Alza, November 2, 1989: EP0339811-A2 (10 worldwide citation)

A dosage form is disclosed comprising a coat that surrounds a drug. The coat comprises a subcoat and an overcoat thermally annealed to provide a single unit coat around the drug.


3
Jordan Maureen L, Ayer Atul Devdatt, Magruder Paul R, Edgren David Emil: Forme posologique, comprenant une couche a liberation rapide et une couche a liberation lente. Alza, March 10, 1989: FR2620025-A1 (6 worldwide citation)

La forme posologique 10 comprend une paroi 12 percée d'au moins un orifice 13 et entourant un compartiment 15 contenant une première couche 16 à libération rapide et une seconde couche 17 à libération lente. La paroi 12 est en une composition semi-perméable, laissant passer les fluides extérieurs ma ...


4
Edgren David Emil, Magruder Judy A, Bhatti Gurdish Kaur: Controlled-release oral dosage forms comprising different cellulose ethers.. Alza, February 20, 1991: EP0413061-A1 (4 worldwide citation)

A dosage form is disclosed comprising a low number average molecular weight hydroxypropylmethylcellulose, a high number average molecular weight hydroxypropylmethylcellulose, and a beneficial drug.


5
Edgren David Emil, Magruder Judy A, Bhatti Gurdish Kaur: Forme posologique a liberation controlee comprenant divers esters cellulosiques, Controlled release dosage form comprising different cellulose ethers. Alza Corporation, SMART & BIGGAR, June 27, 1995: CA1336070 (3 worldwide citation)

A dosage form is disclosed comprising a low number averagemolecular weight hydroxypropylmethylcellulose, a high number averagemolecular weight hydroxypropylmethylcellulose, and a beneficial drug.


6

7
Edgren David Emil, Bhatti Gurdish Kaur: Oral osmotic device.. Alza, October 5, 1994: EP0617611-A1 (1 worldwide citation)

An osmotic device (10) for delivering a beneficial drug, such as an anti-microbial drug, into the mouth of a human patient is disclosed. The device (10) has a size and shape adapting it to be comfortably retained in the mouth for extended periods of time. The device comprises a thin semipermeable me ...


8
Edgren David Emil, Bhatti Gurdish Kaur: Oral osmotic device. Alza Corporation, DUVALL Jean M, June 24, 1993: WO/1993/011748 (1 worldwide citation)

An osmotic device (10) for delivering a beneficial drug, such as an anti-microbial drug, into the mouth of a human patient is disclosed. The device (10) has a size and shape adapting it to be comfortably retained in the mouth for extended periods of time. The device comprises a thin semipermeable me ...


9
Edgren David Emil, Theeuwes Felix: Composition aqueuse denrobage pour comprimes pharmaceutiques, Aqueous based pharmaceutical coating composition for dosage forms. Alza Corporation, SMART & BIGGAR, October 10, 1995: CA1337275

A dosage form is disclosed comprising a coat that surrounds adrug. The coat comprises a subcoat and an overcoat thermallyannealed to provide a single unit coat around the drug.


10
Edgren David Emil, Magruder Judy A, Bhatti Gurdish Kaur: Forme galenique comprenant des couches paralleles, Dosage form comprising parallel laminae. Alza Corporation, SMART & BIGGAR, August 30, 1994: CA1331739

ABSTRACT OF THE INVENTIONA bilaminated dosage form is disclosed comprising at least 30weight percent cellulose ether, a first lamina and a second lamina witheach lamina comprising a different cellulose ether formulation, and adrug in at least one of the lamina.